Tiziana Life Sciences (LON:TILS) Trading Up 8.3% – What’s Next?

Tiziana Life Sciences PLC (LON:TILS) traded up 8.3% during trading on Friday . The company traded as high as GBX 59 ($0.74) and last traded at GBX 58.50 ($0.74). 297,127 shares changed hands during trading, a decline of 43% from the average session volume of 522,223 shares. The stock had previously closed at GBX 54 ($0.68).

Tiziana Life Sciences Stock Up 8.3 %

The business’s 50 day moving average price is GBX 58.50 and its 200 day moving average price is GBX 58.50. The firm has a market cap of £113.85 million and a price-to-earnings ratio of -3.59. The company has a debt-to-equity ratio of 2.36, a quick ratio of 6.41 and a current ratio of 6.54.

About Tiziana Life Sciences

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.